Нарушения углеводного и жирового обмена при первичном гиперпаратиреозе

1. Akgun S. and Ertel N.H. Hyperparathyroidism and coexisting diabetes mellitus: altered carbohydrate metabolism // Archives of Internal Medicine 1978, 138: 1500-1502.

2. Austin M.A. et al. Hypertrigliceridemia as a cardiovascular risk factor // American J of Cardiology 1998; 81:7B-12B.

3. Baigent C. et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomized trials of statins // Lancet 2005, 366: 1267-1278

4. Bannon M.P. et al. The relationship between primary hyperparathyroidism and diabetes mellitus // Annals of Surgery 1988, 207: 430-433.

5. Bolland M.J. et al. Association between primary hyperparathyroidism and increased body weight: a meta-analysis // J Clin Endocrinology&Methabolism 2005, 90 (3): 1525-1530.

6. Bolland M.J. et al. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women // Bone 2006, 38(3): 317-321.

7. Bonora E. et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study // Diabetes 1998, 47: 1643-1649.

8. Chang C.J. et al. Ventricular tachycardia in a patient with primary hyperparathyroidism // Pacing Clin Electrophysiol 2000, 23: 534-537.

9. Cheung P.S. et al. Effect of hyperparathyroidism on the control of diabetes mellitus // Surgery 1986, 100: 1039-1047.

10. Christensson T. and Einarsson K. Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidism // Clinica Chemica Acta 1977, 78: 411-415.

11. Christiansen P. et al. Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study // Bone 1999, 25: 597-602.

12. Dalberg K. et al. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study // Eur J Surg 1996, 162: 171-176.

13. De la Torre N.G. et al. Parathyroid adenomas and cardiovascular risk // Endocrine-related cancer 2003, 10: 309-322.

14. DeFronzo R.A. and Lang R. Hypophosphatemia and glucoseintolerance: evidence for tissue insensitivity to insulin // New England J of Medicine 1980, 303: 1259-1263.

15. Delfini E., Petramala L. et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism // Metabolism 2007, 56(1): 30-36.

16. Dominiczak A.F., Lyall F., Morton J.J. et al. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism.// Clin Sci 1990, 78: 127-132.

17. Dorheim M.A. et al. Osteoblastic gene expression during adipogenesis in hematopoetic supporting murine bone marrow stromal cells // J Cell Physiol 1993, 154: 317-328.

18. Erem C. et al. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-dimer levels // Exp Cin Endocrinol Diabetes 2008, 16: 324-330.

19. Grey A. and Reid I. Body weight and bone mineral density in hyperparathyroidism // Ann Intern Med 1995, 123: 732.

20. Haap M. et al. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects // Eur J Clin Nutr 2006, 60(6): 734-739.

21. Hagstroem E. et al. Normalized dyslipidemia after parathyroidectomy in mild primary hyperparathyroidism: population based study over five years // Clin Endocrinol 2002, 56(2): 253-260.

22. Hagstroem E. et al. Metabolic abnormalities in patients with normocalcemic hyper-parathyroidism detected at a population-based screening // European J of Endocrinology 2006, 155: 33-39.

23. Hagstroem E. et al. Serum calcium is independently associated with insulin sensitivity measured with euglycemic-hyperinsulinaemic clamp in community-based cohort // Diabetologia 2007, 50 (2): 317-324.

24. Hedback G. and Oden A. Increased risk of death from PHPT-an update // Eur J Clin Invest 1998, 28: 271-276.

25. Kautzky-Willer A. et al. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery // Clinical Endocrinology 1992, 37: 147-155.

26. Knaheli A.A. et al. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy // Diabetes Metab Res Rev 2007, 23(1): 43-48.

27. Kosch M. et al. Studies on flow-mediated vasodilatation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism // Am J Hypertens 2000, 13: 759-764.

28. Krauss R.M. Atherogenicity of triglyceride rich lipoproteins// American J of cardiology 1998, 81: 13B-17B.

29. Kumar S. et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism // Clinical Endocrinology 1994, 40: 47-53

30. Lacour B. et al. Serum lipoprotein disturbances in primary and secondary hyperparathyroidism and effects of parathyroidectomy // Amercian J of Kidney Diseases 1986, 8: 422-429

31. Ljunghall S. et al. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy // European Journal of Clinical Investigation 1983, 13: 373-377.

32. Lundgren E. et al. Case-control study on symptoms and signs of asymptomatic primary hyperparathyroidism // Surgery 1998, 124: 980-986.

33. McCarty M.F. and Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight // Med Hypotheses 2003, 61: 535-542.

34. NIH Consensus Development Conference Statement. Triglyceride, high density lipoprotein, and coronary heart disease. NIH Development Panel on Triglyceride, High density lipoproteins and coronary heart disease // J of the American Medical Association 1993, 269: 505-510.

35. Piovesan A. et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy // Clin Endocrinol 1999, 50: 321-328.

36. Prager R. et al. Peripheral insulin resistance in primary hyperparathyroidism // Metabolism 1983, 32: 800-805.

37. Prager R. et al. Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery // Calcified Tissue International 1990, 46: 1-4.

38. Procopio M. et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism // Diabetic Medicine 2002, 19: 958-961.

39. Procopio M. and Boretta G. Derangement of glucose metabolism in Hyperparathyroidism // J Endocrinol Invest 2003, 26(1): 1136-1142.

40. Quin J.D. and Gumpert J.R. Remission of non-insulin-dependent diabetes mellitus following resection of a parathyroid adenoma // Diabetic Medicine 1997, 14: 80-81.

41. Richards M.L. and Thompson N.W. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? // Surgery 1999, 126: 1160-1166.

42. Scherrer U. and Sartori C. Defective nitric oxide synthesis. A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity // European Journal of Endocrinology 2000, 142: 315-323.

43. Stampfer M.J. et al. A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction // J of the American Medical Association 1996, 276: 882-888.

44. Taylor W.H. The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives // Diabetic Medicine 1991, 8: 683-687.

45. Taylor W.H., Khaleeli A.A. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus // Diabetic Medicine 1997, 14: 386-389.

46. Valdemarsson S. et al. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism // European J of Endocrinology 1996, 134: 320-325.

47. Valdemarsson S. et al. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of parathyroidectomy // J Inter Med 1998, 244(3): 241-249.

48. Vaziri N.D. et al. Lipid fractions in primary hyperparathyroidism before and after surgical cure // Acta Endocrinol (Copenh) 1983, 10: 539-542.

49. Wermers R.A. et al. Survival after diagnosis of PHPT: a population based study // Am J Med 1998, 104: 115-122.

50. Westerdahl et al. Urate and arteriosclerosis in primary hyperparathyroidism // Clin Endocrinol 2001, 54(6): 805-811.